• Ligand Licenses VER250840 to Cumulus Oncology americanpharmaceuticalreview
    May 23, 2019
    Ligand Pharmaceuticals announced the signing of a license agreement granting Cumulus Oncology exclusive worldwide rights to develop and commercialize VER250840 ...
PharmaSources Customer Service